Sun Pharma Secures Bridge Loan for $12 Billion Organon Purchase

Sun Pharmaceutical Industries Ltd. has lined up a short-term loan to help finance its $12 billion acquisition of New York-listed healthcare company Organon & Co.,according to people familiar with the transaction.

At least three banks — Mitsubishi UFJ Financial Group Inc., JPMorgan Chase & Co. and Citigroup Inc. — have committed to provide the funding, though the final size may change as the deal takes shape, the people said, asking not to be identified because the information is private.

The bridge facility, if drawn, may run for 12-18 months, they said.

The financing highlights both the scale of ...